Interleukin-21: updated review of Phase I and II clinical trials in metastatic renal cell carcinoma, metastatic melanoma and relapsed/refractory indolent non-Hodgkin's lymphoma-Reference-Cited by-同舟云学术

Interleukin-21: updated review of Phase I and II clinical trials in metastatic renal cell carcinoma, metastatic melanoma and relapsed/refractory indolent non-Hodgkin's lymphoma

Published:2010-04-12 Issue:5 Volume:10 Page:807-817
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Hashmi Mehmood H,Van Veldhuizen Peter J

Publisher

Informa Healthcare

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

http://www.tandfonline.com/doi/pdf/10.1517/14712598.2010.480971

Reference48 articles.

1. Interleukin-21: biology and application to cancer therapy

2. Interleukin-21: Basic Biology and Implications for Cancer and Autoimmunity

3. Interleukin 21: a cytokine/cytokine receptor system that has come of age

4. Biology of IL-21 and the IL-21 receptor

5. Cancer Statistics, 2009

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukins and interferons in mesenchymal stromal stem cell-based gene therapy of cancer;Cytokine & Growth Factor Reviews;2024-06

2. Cytokines and their role as immunotherapeutics and vaccine Adjuvants: The emerging concepts;Cytokine;2023-09

3. Anti-Claudin18.2-IL-21 fusion protein bifunctional molecule has more powerful anti-tumor effect and better safety;International Immunopharmacology;2023-02

4. EBV dUTPase: A Novel Modulator of Inflammation and the Tumor Microenvironment in EBV-Associated Malignancies;Cancers;2023-01-30

5. Cancer Immunotherapy Beyond Checkpoint Blockade;JACC: CardioOncology;2022-12